Skip to Content
Merck
  • Salutary effect of calcium channel blockade following hypoxic and septic insult.

Salutary effect of calcium channel blockade following hypoxic and septic insult.

The journal of trauma and acute care surgery (2014-07-01)
Abubaker A Ali, Sean Mutchnick, David M Liberati, Lawrence N Diebel
ABSTRACT

Intestinal ischemia and reperfusion is a major problem associated with a high morbidity and mortality following trauma and hemorrhagic shock. Apoptosis is the major mode of cell death following reperfusion. The cytoskeleton damage precedes the apoptotic final microscopic features. Calcium plays a central role in apoptosis. Therefore, we studied whether verapamil could preserve the function of the cytoskeleton in an in vitro intestinal model following hypoxia-reoxygenation (H/R). Our goal was to assess mainly the cytoskeleton functions, which includes IgA transport and the cell monolayer barrier integrity. Confluent HT29 intestinal monolayers grown in a two-chamber cell culture system were held under hypoxic (5% CO2) conditions for 90 minutes followed by normoxia (21% O2) (H/R). Cell subsets were exposed to lipopolysaccharide (10 μg/mL) before H/R. Verapamil (8 μM) was added to HT29 cell subsets after H/R treatment. Dimeric IgA was added to the basal compartment, and apical media were sampled at intervals to quantitate IgA transcytosis using enzyme-linked immunosorbent assay. HT29 cells held under normoxic conditions served as controls. HT29 permeability to FD4 was assessed at the end of each experiment. In a separate experiment, HT29 cells were stained for F actin using rhodamine-labeled phalloidin. Intestinal monolayer permeability was increased following treatment with H/R and/or lipopolysaccharide. Verapamil treatment prevented increased permeability in HT29 cells and led to an increase in IgA transport. Disruption of actin microfilaments was demonstrated following H/R insult but was abrogated by the addition of verapamil following H/R insult. Reperfusion can lead to both physical and immune derangement of epithelial cell barrier function. Verapamil may be important in preserving gut barrier function. Additional studies including in vivo confirmation in animal shock models are needed to validate these findings.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fluorescein 5(6)-isothiocyanate, ≥90% (HPLC)
Sigma-Aldrich
Fluorescein 5(6)-isothiocyanate, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Dextran 70 for calibration, Dextran 70 European Pharmacopoeia (EP) Reference Standard
Dextran 10 for calibration, Dextran 10 European Pharmacopoeia (EP) Reference Standard
Dextran 40 for calibration, Dextran 40 European Pharmacopoeia (EP) Reference Standard
Dextran 250 for calibration, Dextran 250 European Pharmacopoeia (EP) Reference Standard
Dextran 40 for performance test, Dextran 40 European Pharmacopoeia (EP) Reference Standard
Dextran 60/70 for performance test, Dextran 60/70 European Pharmacopoeia (EP) Reference Standard
Dextran EP Reference Standard, European Pharmacopoeia (EP) Reference Standard
USP
Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard
Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
Dextran from Leuconostoc mesenteroides, analytical standard, suitable for gel permeation chromatography (GPC), Mw 25,000
Supelco
Dextran, analytical standard, suitable for gel permeation chromatography (GPC), Set Mp 1,000-400,000
Sigma-Aldrich
Dextran from Leuconostoc mesenteroides, average mol wt 9,000-11,000
Sigma-Aldrich
Dextran from Leuconostoc mesenteroides, average mol wt 1,500,000-2,800,000
Sigma-Aldrich
Dextran from Leuconostoc mesenteroides, average mol wt 15,000-30,000
Sigma-Aldrich
Fluorescein isothiocyanate isomer I, ≥97.5% (HPLC)
Dextran 4 for calibration, Dextran 4 European Pharmacopoeia (EP) Reference Standard
Dextran 1, Dextran 1 European Pharmacopoeia (EP) Reference Standard
Supelco
Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Dextran Vo, Dextran Vo European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dextran solution from Leuconostoc mesenteroides, 20 % (w/w) (Autoclaved)
Sigma-Aldrich
Dextran from Leuconostoc spp., Mr 450,000-650,000
Supelco
Dextran from Leuconostoc mesenteroides, analytical standard, suitable for gel permeation chromatography (GPC), Mw 5,000
Supelco
Dextran, analytical standard, 1,000
Sigma-Aldrich
Dextran from Leuconostoc spp., Mr ~6,000
Sigma-Aldrich
Dextran from Leuconostoc mesenteroides, Mr ~200,000
Sigma-Aldrich
Dextran from Leuconostoc spp., Mr ~70,000
Supelco
Dextran from Leuconostoc mesenteroides, analytical standard, suitable for gel permeation chromatography (GPC), Mw 670,000
Supelco
Dextran, analytical standard, 80,000